Literature DB >> 22488129

Incidence of liver abnormalities in Fanconi anemia patients.

Caroline Masserot-Lureau1, Nadir Adoui, Françoise Degos, Cédric de Bazelaire, Jean Soulier, Sylvie Chevret, Gérard Socié, Thierry Leblanc.   

Abstract

Patients with Fanconi anemia (FA) are prone to liver tumors, especially after androgen treatment, but other liver abnormalities have not been described for these patients. Here, we systematically reviewed liver manifestations in a cohort of 64 adult and pediatric patients with FA followed in a single center. "Significant biological liver abnormalities(SBLA)" in the absence of any androgen treatment were found in five patients, including two children, belonging to rare FA groups; these two patients presented with a very severe chronic cytolysis pattern which may be classified as a new FA phenotype. Liver radiological abnormalities, which include hepatic tumors (n 5 4), hepatomegaly(n 5 1), hyperechogenicity (n 5 2), and a previously undescribed biliary duct dilatation as demonstrated by magnetic resonance cholangiopancreatography(MRCP) (n 5 2), were found in eight patients who received androgen treatment or who had iron overload. Lastly, we found no correlation between cytolysis intensity and high levels of alpha-fetoprotein (AFP); this common finding in FA patients cannot therefore be explained by hepatocyte regeneration.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22488129     DOI: 10.1002/ajh.23153

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  8 in total

Review 1.  Fanconi anemia: current insights regarding epidemiology, cancer, and DNA repair.

Authors:  Jasmine D Peake; Eishi Noguchi
Journal:  Hum Genet       Date:  2022-05-21       Impact factor: 5.881

Review 2.  Alcohol, stem cells and cancer.

Authors:  Shoujun Gu; Bao-Ngoc Nguyen; Shuyun Rao; Shulin Li; Kirti Shetty; Asif Rashid; Vivek Shukla; Chu-Xia Deng; Lopa Mishra; Bibhuti Mishra
Journal:  Genes Cancer       Date:  2017-09

3.  Fatal Myelotoxicity Following Palliative Chemotherapy With Cisplatin and Gemcitabine in a Patient With Stage IV Cholangiocarcinoma Linked to Post Mortem Diagnosis of Fanconi Anemia.

Authors:  Nils W Engel; Simon Schliffke; Ulrich Schüller; Christian Frenzel; Carsten Bokemeyer; Christian Kubisch; Davor Lessel
Journal:  Front Oncol       Date:  2019-05-22       Impact factor: 6.244

Review 4.  Fanconi anemia and dyskeratosis congenita/telomere biology disorders: Two inherited bone marrow failure syndromes with genomic instability.

Authors:  Moisés Ó Fiesco-Roa; Benilde García-de Teresa; Paula Leal-Anaya; Renée van 't Hek; Talia Wegman-Ostrosky; Sara Frías; Alfredo Rodríguez
Journal:  Front Oncol       Date:  2022-08-25       Impact factor: 5.738

5.  Benign hepatocellular tumors in children: focal nodular hyperplasia and hepatocellular adenoma.

Authors:  Stéphanie Franchi-Abella; Sophie Branchereau
Journal:  Int J Hepatol       Date:  2013-03-11

6.  Pathological Diagnosis of Hepatocellular Cellular Adenoma according to the Clinical Context.

Authors:  Paulette Bioulac-Sage; Christine Sempoux; Laurent Possenti; Nora Frulio; Hervé Laumonier; Christophe Laurent; Laurence Chiche; Jean Frédéric Blanc; Jean Saric; Hervé Trillaud; Brigitte Le Bail; Charles Balabaud
Journal:  Int J Hepatol       Date:  2013-04-18

7.  BRIP1 coding variants are associated with a high risk of hepatocellular carcinoma occurrence in patients with HCV- or HBV-related liver disease.

Authors:  Abderrahim Oussalah; Patrice Hodonou Avogbe; Erwan Guyot; Céline Chery; Rosa-Maria Guéant-Rodriguez; Nathalie Ganne-Carrié; Aurélie Cobat; Darius Moradpour; Bertrand Nalpas; Francesco Negro; Thierry Poynard; Stanislas Pol; Pierre-Yves Bochud; Laurent Abel; Hélène Jeulin; Evelyne Schvoerer; Nicodème Chabi; Emile Amouzou; Ambaliou Sanni; Hélène Barraud; Pierre Rouyer; Thomas Josse; Laetitia Goffinet; Jean-Louis Jouve; Anne Minello; Claire Bonithon-Kopp; Gérard Thiefin; Vincent Di Martino; Michel Doffoël; Carine Richou; Jean-Jacques Raab; Patrick Hillon; Jean-Pierre Bronowicki; Jean-Louis Guéant
Journal:  Oncotarget       Date:  2016-08-17

8.  Ablating putative Ku70 phosphorylation sites results in defective DNA damage repair and spontaneous induction of hepatocellular carcinoma.

Authors:  Janapriya Saha; Jinsung Bae; Shih-Ya Wang; Huiming Lu; Lori J Chappell; Purva Gopal; Anthony J Davis
Journal:  Nucleic Acids Res       Date:  2021-09-27       Impact factor: 16.971

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.